Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2021-08-02 00:00:00 ET · period of report 2021-07-29 · accession 0000899243-21-031092 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-02 | 2021-07-29 | CADL | Canepa John J | CFO | P - Purchase | $8.00 | +10.1K | 10.1K | New | +$81.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-29 | P | A | 10,125 | $8.00 | 10,125 | D | — | — |